Covered recipient · General Payments record
JORGE J LEAL
Allopathic & Osteopathic Physicians Urology
General Payments · PY2019–2024
$8,695.83
- Reported across 137 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $2,838.23 | 62 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Merck Sharp & Dohme Corporation | $332.96 | 14 |
| Genmab U.S., Inc. | $277.11 | 3 |
| GENZYME CORPORATION | $260.77 | 3 |
| Amgen Inc. | $232.41 | 2 |
| Janssen Biotech, Inc. | $156.69 | 4 |
| Acerta Pharma LLC | $154.19 | 3 |
| Pharmacosmos Therapeutics Inc. | $148.74 | 2 |
| Astellas Pharma US Inc | $136.68 | 2 |
| Gilead Sciences, Inc. | $124.46 | 1 |
| GlaxoSmithKline, LLC. | $124.46 | 1 |
| E.R. Squibb & Sons, L.L.C. | $124.46 | 1 |
| RECORDATI_RARE_DISEASES_INC. | $124.46 | 1 |
| Regeneron Healthcare Solutions, Inc. | $117.02 | 2 |
| Incyte Corporation | $93.65 | 4 |
| Bayer HealthCare Pharmaceuticals Inc. | $62.13 | 3 |
| EISAI INC. | $56.60 | 3 |
| Deciphera Pharmaceuticals Inc. | $50.41 | 2 |
| SERVIER PHARMACEUTICALS LLC | $49.90 | 2 |
| Alexion Pharmaceuticals, Inc. | $44.05 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $30.40 | 1 |
| Genentech USA, Inc. | $28.23 | 1 |
| SOBI, INC | $25.23 | 1 |
| Sumitomo Pharma America, Inc. | $23.20 | 1 |
| Mirati Therapeutics, Inc. | $21.93 | 1 |
| PFIZER INC. | $19.05 | 1 |
| PUMA BIOTECHNOLOGY, INC. | $19.04 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (62)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.